| http://www.w3.org/ns/prov#value | - Estimate the incidence of PML in Tysabri-treated patients who are anti-JCV antibody negative and anti-JCV antibody positive, based on a meta-analysis of data obtained from this study and other data sources. [ Time Frame: Unknown ] [ Designated as safety issue: Yes ]
|
